DRW Securities, LLC

Broker-Dealer

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1481986 CHICAGO, IL

Position in APLS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,350,641

New position

Shares Held

33,573

first reported quarter

Ownership

0.026%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#162

of 320 holders

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

DRW Securities, LLC holds $19,602,546 across 58 Biotechnology names. APLS ranks #1 (6.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APLS	Apellis Pharmaceuticals, Inc. This page	33,573	$1,350,641
2	PTCT	Ptc Therapeutics, Inc.	18,169	$1,237,853
3	KURA	Kura Oncology, Inc.	132,174	$1,074,574
4	FOLD	AMICUS THERAPEUTICS, INC.	70,670	$1,021,888
5	ARGX	Argenx SE	1,247	$910,621
6	MNKD	Mannkind Corp	305,121	$747,546
7	BMRN	Biomarin Pharmaceutical Inc	12,426	$701,944
8	INSM	INSMED Inc	3,698	$604,696

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,350,641	33,573	—	Shares	Other	2026-05-13
No filing history on record for this holder in this stock.